Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT04197791
What this trial is testing

Effect of Core Stabilization Exercises and Neuromuscular Electrical Stimulation in Patients With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Istanbul University - Cerrahpasa 36
Large-scale testing (Phase 3)Study completedNCT00071461
What this trial is testing

Efficacy and Safety of Oral Bosentan in Patients With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Actelion 158
Not applicableEnrolling By InvitationNCT06629623
What this trial is testing

Current Status of Diagnosis, Treatment and Quality of Life for Patients with Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Chu Hongling 310
Large-scale testing (Phase 3)Study completedNCT00650091
What this trial is testing

Evaluating the Effectiveness of Prednisone, Azathioprine, and N-acetylcysteine in Patients With IPF

Who this might be right for
Pulmonary Fibrosis
Duke University 264
Early research (Phase 1)Study completedNCT05195918
What this trial is testing

Study of Oral Epigallocatechin-3-gallate (EGCG) in IPF Patients

Who this might be right for
Idiopathic Pulmonary Fibrosis
Hal Chapman 50
Not applicableActive Not RecruitingNCT07048652
What this trial is testing

Evaluating the Diagnostic Performance of (HRCT) in IPD Fibrosis in Suspected Cases

Who this might be right for
Idiopathic Pulmonary Fibrosis
Superior University 68
Not applicableStudy completedNCT05022784
What this trial is testing

Adherence to Nintedanib Among Idiopathic Pulmonary Fibrosis Patients

Who this might be right for
Idiopathic Pulmonary Fibrosis
Boehringer Ingelheim 1,798
Large-scale testing (Phase 3)Study completedNCT01619085
What this trial is testing

Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Boehringer Ingelheim 752
Testing effectiveness (Phase 2)Study completedNCT01766817
What this trial is testing

Safety and Efficacy of a Lysophosphatidic Acid Receptor Antagonist in Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Bristol-Myers Squibb 325
Testing effectiveness (Phase 2)WithdrawnNCT01524068
What this trial is testing

Study of Combined PEX, Rituximab, and Steroids in Acute Idiopathic Pulmonary Fibrosis Exacerbations

Who this might be right for
Idiopathic Pulmonary Fibrosis
University of Pittsburgh
Early research (Phase 1)Study completedNCT02874989
What this trial is testing

Targeting Pro-Inflammatory Cells in Idiopathic Pulmonary Fibrosis: a Human Trial

Who this might be right for
Idiopathic Pulmonary Fibrosis (IPF)
Wake Forest University Health Sciences 26
Not applicableStudy completedNCT03979430
What this trial is testing

Early Detection of Acute Exacerbation in Patients With Idiopathic Lung Fibrosis - a Pilot Study

Who this might be right for
Acute ExacerbationIdiopathic Pulmonary FibrosisHome Spirometry
Heidelberg University 47
Testing effectiveness (Phase 2)Study completedNCT01170065
What this trial is testing

Roll Over Study From 1199.30 BIBF 1120 in Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Pulmonary Fibrosis
Boehringer Ingelheim 198
Not applicableActive Not RecruitingNCT00258544
What this trial is testing

Microarray Analysis of Gene Expression in Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Pulmonary Fibrosis
University of Pittsburgh 80
Testing effectiveness (Phase 2)Study completedNCT04071769
What this trial is testing

Genentech Xenon MRI Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Duke University 34
Not applicableStudy completedNCT01637831
What this trial is testing

CPAP Therapy in Patients With Idiopathic Pulmonary Fibrosis and Sleep Apnea

Who this might be right for
Obstructive Sleep ApneaIdiopathic Pulmonary Fibrosis
University of Crete 12
Not applicableStudy completedNCT01982968
What this trial is testing

Treatment of IPF With Laparoscopic Anti-Reflux Surgery

Who this might be right for
Idiopathic Pulmonary FibrosisGastroesophageal Reflux
University of California, San Francisco 58
Testing effectiveness (Phase 2)Looking for participantsNCT06189820
What this trial is testing

Role of the Fibroblast Activation Protein (FAP) as Biomarker of Fibrotic Lung Diseases

Who this might be right for
Pulmonary FibrosisLung FibrosisIdiopathic Pulmonary Fibrosis+1 more
Erasme University Hospital 70
Testing effectiveness (Phase 2)Study completedNCT00080223
What this trial is testing

Safety Study of Oral Pirfenidone in Patients With Pulmonary Fibrosis/Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary FibrosisPulmonary Fibrosis
Genentech, Inc. 83
Early research (Phase 1)Study completedNCT06717100
What this trial is testing

Study to Determine Potential for Drug-drug Interactions When Co-administering Deupirfenidone (LYT-100) and Nintedanib

Who this might be right for
Drug Interactions
PureTech 24
Next Page